Nine Square Therapeutics is discovering and delivering novel small-molecule therapeutics for Parkinson’s disease, amyotrophic lateral sclerosis (ALS) and non-degenerative forms of movement disorders such as essential tremors and dyskinesias – diseases for which patients are urgently awaiting more effective treatments.
